Colorectal Cancer Alliance announces key leadership appointments: Brian Cowart as Chief Development Officer and Marc Mason as Senior VP of Data Intelligence & Technology, strengthening the organization’s mission to end colorectal cancer through strategic growth and innovation.
Oluwadamilola (Dammie) Brown, M.D., joins as the senior vice president of mission delivery, and Tina Zeff joins as chief operating officer of the Alliance.
With 23andMe, the Alliance seeks another avenue to educate Black communities about the importance of knowing their family health history and risk factors to prevent colorectal cancer or find it at an early stage when it is most treatable.
Project Cure CRC, the breakthrough research fund of the national nonprofit Colorectal Cancer Alliance (Alliance), has announced the first five awardees of funds to advance urgent science for today’s colorectal cancer patients.
The Every Day is a Gift Gala will take place from 8:00 p.m. to midnight (PST) on Friday, June 21, 2024, at BMO Stadium’s Sunset Deck in Los Angeles, California.
The new initiative raises awareness of Colorectal Cancer Alliance support services and screening to curb the rising rates of colorectal cancer, the second deadliest cancer in the U.S.
In an effort to expedite its life-saving work, the Colorectal Cancer Alliance (Alliance) Project Cure CRC initiative is excited to open its Request for Proposals (RFP). Tens of millions of dollars will be available to researchers from around the world whose work aims to expedite colorectal cancer (CRC) research to a curable science.
Initiative aims to reduce stigma and educate about screening choices, as the Colorectal Cancer Alliance launches a health equity fund to decrease disparities.
Mancini, a stage III colorectal cancer survivor, was presented with the Blue Star Award, which honors an individual who displays conviction and unwavering dedication to the Alliance’s mission.
In a critical step forward in the mission to end colorectal cancer (CRC), the nation’s leading CRC nonprofit organization, the Colorectal Cancer Alliance (Alliance), announces the establishment of Project Cure CRC.
The Colorectal Cancer Alliance (Alliance), the nation's largest nonprofit organization dedicated to colorectal cancer, is reinforcing its commitment to health equity through a partnership with Cottonelle® and BLKHLTH®, a nonprofit organization dedicated to reducing the impact of racism on Black healthcare.
The Colorectal Cancer Alliance (Alliance), a national nonprofit committed to ending this disease, strongly disagrees with the colorectal cancer screening guidance issued yesterday by the American College of Physicians (ACP), which suggests people at average risk start getting checked at age 50 — five years later than recommended by other institutions.
Jerry Tillery joins the Alliance as its first Chief Impact Officer, a role designed to ensure continued success throughout the organization’s programmatic and operational functions as they reach a broader population.
The Alliance supports President Biden's nomination of Dr. Monica Bertagnolli for Director of the National Institutes of Health Her innovative efforts in cancer prevention, early detection, and creating a national navigation program for childhood cancers are significant strides toward eradicating this disease. Her dedication is demonstrated further by initiatives to enhance data infrastructure and clinical research to benefit patients.
The Alliance’s LEAD FROM BEHIND initiative has been named Best Video in Public Service & Activism 2023 in the 27th Annual Webby Awards Internet Celebration. The Webby Awards, presented by the International Academy of Digital Arts and Sciences (IADAS), is the leading international awards organization honoring excellence on the Internet. Winning a Webby is an unparalleled honor and a remarkable achievement.
A federal judge struck down a provision of the Affordable Care Act (ACA) that requires insurance companies to follow U.S. Preventive Service Task Force (USPSTF) guidelines and cover the cost of certain preventive cancer screenings, including tests for colorectal cancer. If not paused or overturned, millions of people stand to lose insurance coverage for colonoscopy, stool-DNA, FIT, and other tests for colorectal cancer, the second deadliest cancer among men and women combined in the United States.
Since the launch of the Cancer Moonshot initiative in 2016, the cancer community has made measurable progress toward three ambitious goals: to accelerate scientific discovery in cancer, foster greater collaboration, and improve the sharing of cancer data. Today’s Forum, focused specifically on colorectal cancer, provides an opportunity to highlight the significant impact that increased screening and prevention could have on reducing colorectal cancer deaths.
